Ilia I. Ouspenski

Array ( [id] => 4431626 [patent_doc_number] => 07968300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Method of isolating regulatory T cells from human samples' [patent_app_type] => utility [patent_app_number] => 11/943682 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 10694 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968300.pdf [firstpage_image] =>[orig_patent_app_number] => 11943682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5445991 [patent_doc_number] => 20090047217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby' [patent_app_type] => utility [patent_app_number] => 11/943501 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31798 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047217.pdf [firstpage_image] =>[orig_patent_app_number] => 11943501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8352210 [patent_doc_number] => 08247537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Human monoclonal antibodies to BTLA and methods of use' [patent_app_type] => utility [patent_app_number] => 12/515004 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 42 [patent_no_of_words] => 40186 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 491 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12515004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4516206 [patent_doc_number] => 07932358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'Antibodies to JTT-1 protein and cells secreting such antibodies' [patent_app_type] => utility [patent_app_number] => 11/938753 [patent_app_country] => US [patent_app_date] => 2007-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 39 [patent_no_of_words] => 31340 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932358.pdf [firstpage_image] =>[orig_patent_app_number] => 11938753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820441 [patent_doc_number] => 20080226634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'TES7 AND ANTIBODIES THAT BIND THERETO' [patent_app_type] => utility [patent_app_number] => 11/937470 [patent_app_country] => US [patent_app_date] => 2007-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 28021 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226634.pdf [firstpage_image] =>[orig_patent_app_number] => 11937470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5330649 [patent_doc_number] => 20090111126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'MAMMALIAN CELL-BASED IMMUNOGLOBULIN DISPLAY LIBRARIES' [patent_app_type] => utility [patent_app_number] => 11/933819 [patent_app_country] => US [patent_app_date] => 2007-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18164 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111126.pdf [firstpage_image] =>[orig_patent_app_number] => 11933819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4570689 [patent_doc_number] => 07824679 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Human monoclonal antibodies to CTLA-4' [patent_app_type] => utility [patent_app_number] => 11/981810 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 59 [patent_no_of_words] => 32330 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/824/07824679.pdf [firstpage_image] =>[orig_patent_app_number] => 11981810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4938405 [patent_doc_number] => 20080075724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Molecules designated B7L-1' [patent_app_type] => utility [patent_app_number] => 11/981954 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14250 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20080075724.pdf [firstpage_image] =>[orig_patent_app_number] => 11981954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545442 [patent_doc_number] => 08053414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Methods of using B7-DC molecules to induce or enhance an immune response' [patent_app_type] => utility [patent_app_number] => 11/932327 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 30032 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053414.pdf [firstpage_image] =>[orig_patent_app_number] => 11932327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765827 [patent_doc_number] => 20080177039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'B7-H3 and B7-H4, Novel Immunoregulatory Molecules' [patent_app_type] => utility [patent_app_number] => 11/930789 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14909 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20080177039.pdf [firstpage_image] =>[orig_patent_app_number] => 11930789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8028597 [patent_doc_number] => 08143379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Human monoclonal antibodies to CTLA-4' [patent_app_type] => utility [patent_app_number] => 11/981824 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 59 [patent_no_of_words] => 32279 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143379.pdf [firstpage_image] =>[orig_patent_app_number] => 11981824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5311034 [patent_doc_number] => 20090018315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'B7-H3 and B7-H4, Novel Immunoregulatory Molecules' [patent_app_type] => utility [patent_app_number] => 11/930911 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14916 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018315.pdf [firstpage_image] =>[orig_patent_app_number] => 11930911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4739463 [patent_doc_number] => 20080233116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Human monoclonal antibodies to CTLA-4' [patent_app_type] => utility [patent_app_number] => 11/981771 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 31919 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233116.pdf [firstpage_image] =>[orig_patent_app_number] => 11981771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515517 [patent_doc_number] => 08039589 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-10-18 [patent_title] => 'B7-DC variants' [patent_app_type] => utility [patent_app_number] => 11/932471 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 13701 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039589.pdf [firstpage_image] =>[orig_patent_app_number] => 11932471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545586 [patent_doc_number] => 08053558 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Dendritic cell co-stimulatory molecules' [patent_app_type] => utility [patent_app_number] => 11/931653 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 30036 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053558.pdf [firstpage_image] =>[orig_patent_app_number] => 11931653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290017 [patent_doc_number] => 20090022747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'B7-H3 AND B7-H4, NOVEL IMMUNOREGULATORY MOLECULES' [patent_app_type] => utility [patent_app_number] => 11/929481 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14918 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022747.pdf [firstpage_image] =>[orig_patent_app_number] => 11929481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760265 [patent_doc_number] => 08420786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Bispecific antibody targeting a complement factor or complement regulatory protein' [patent_app_type] => utility [patent_app_number] => 11/929279 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26532 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11929279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5428106 [patent_doc_number] => 20090087416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'B7-H3 AND B7-H4, NOVEL IMMUNOREGULATORY MOLECULES' [patent_app_type] => utility [patent_app_number] => 11/929198 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14909 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087416.pdf [firstpage_image] =>[orig_patent_app_number] => 11929198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718619 [patent_doc_number] => 20080241141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY AND DETECTION OF INFLAMMATORY AND IMMUNE-DYSREGULATORY DISEASE, INFECTIOUS DISEASE, PATHOLOGIC ANGIOGENESIS AND CANCER' [patent_app_type] => utility [patent_app_number] => 11/929315 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26548 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241141.pdf [firstpage_image] =>[orig_patent_app_number] => 11929315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4572414 [patent_doc_number] => 07829534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules' [patent_app_type] => utility [patent_app_number] => 11/978701 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 31 [patent_no_of_words] => 22306 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829534.pdf [firstpage_image] =>[orig_patent_app_number] => 11978701 [rel_patent_id] =>[rel_patent_doc_number] =>)